NEW YORK, Jan. 13, 2015 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of purchasers of Roka Bioscience, Inc. common stock (Nasdaq:ROKA) pursuant to its July 17, 2014 initial public offering ("IPO") and/or on the open market between July 17, 2014 and November 6, 2014, inclusive.
According to the lawsuit, Roka's initial public offering documents failed to disclose known trends and uncertainties about the drastic decline in demand for its proprietary Atlas diagnostic instruments that existed at the time of the IPO. On November 6, 2014, after the close of trading, Roka announced a surprise loss of ($0.64) per share for the third quarter of 2014, and admitted that it had not installed any of its Atlas instruments in that quarter. On the subsequent day, Roka's stock price fell from $8.34 to $3.00, on extraordinarily high trading volume.
Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has over 70 attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.
If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein Adler Freeman & Herz LLP by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at www.whafh.com. All e-mail correspondence should make reference to the "Roka investigation."
Attorney Advertising. Prior results do not guarantee or predict a similar outcome.